1-1                                   AN ACT
 1-2     relating to the study of disease management programs for children's
 1-3     asthma and to the establishment of an asthma and allergy research
 1-4     advisory committee.
 1-5           BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 1-6           SECTION 1.  Subtitle D, Title 2, Health and Safety Code, is
 1-7     amended by adding Chapter 95 to read as follows:
 1-8        CHAPTER 95.  CHILDREN'S ASTHMA DISEASE MANAGEMENT PILOT STUDY
 1-9           Sec. 95.001.  CHILDREN'S ASTHMA DISEASE MANAGEMENT PILOT
1-10     STUDY.  (a)  The department by rule shall establish a pilot study
1-11     to compare preventative disease management methods for treating
1-12     children's asthma with traditional methods of treating the disease.
1-13           (b)  The department shall conduct the pilot study in six
1-14     areas of the state, in urban and rural settings.
1-15           (c)  In conducting the pilot study the department shall use
1-16     disease management techniques that are transferable to private
1-17     practice and to other geographical areas of the state.
1-18           (d)  The pilot study may measure the following outcomes:
1-19                 (1)  school absenteeism;
1-20                 (2)  hospitalization;
1-21                 (3)  frequency of asthma symptoms;
1-22                 (4)  impact of the disease on the family; and
1-23                 (5)  economic effects of the disease, including:
1-24                       (A)  income lost by parents as a result of days
 2-1     missed from work; and
 2-2                       (B)  income lost by schools as a result of
 2-3     student absenteeism.
 2-4           (e)  In conducting the pilot study, the department may use
 2-5     the expertise of an academic institution or nonprofit organization.
 2-6           (f)  The department may use prospective simulation-based
 2-7     analysis to project the outcomes in Subsection (d).
 2-8           Sec. 95.002.  REPORT. (a)  Not later than November 1, 2002,
 2-9     the department shall submit to the legislature an interim written
2-10     report containing the findings of the pilot study.
2-11           (b)  Not later than November 1, 2003, the department shall
2-12     submit to the legislature a final written report containing the
2-13     findings of the pilot study and the department's recommendations.
2-14           Sec. 95.003.  EXPIRATION DATE. This chapter expires September
2-15     1, 2005.
2-16           SECTION 2. (a)  The commissioner of public health shall
2-17     establish an asthma and allergy research advisory committee.
2-18           (b)  The asthma and allergy research advisory committee is
2-19     composed of nine members appointed by the governor, in consultation
2-20     with the lieutenant governor and the speaker of the house of
2-21     representatives.
2-22           (c)  The governor shall select members of the asthma and
2-23     allergy research advisory committee based on the members'
2-24     experience, expertise, or special interest in asthma and allergy
2-25     and:
2-26                 (1)  asthma and allergy education;
2-27                 (2)  indoor air quality;
 3-1                 (3)  the public school system and its dealings with
 3-2     children with asthma and an allergy;
 3-3                 (4)  epidemiology;
 3-4                 (5)  pharmacology;
 3-5                 (6)  parenting a child with asthma or an allergy; or
 3-6                 (7)  immunology.
 3-7           (d)  The commissioner of public health shall select a member
 3-8     of the asthma and allergy research advisory committee to serve as
 3-9     the presiding officer of the committee.  The presiding officer may
3-10     not be an officer or employee of the state.
3-11           (e)  The asthma and allergy research advisory committee
3-12     shall:
3-13                 (1)  develop a plan to research asthma and allergy and
3-14     medical conditions associated with asthma and allergy in this
3-15     state;
3-16                 (2)  assess the resources and talent of institutions in
3-17     this state as possible sites for research opportunities;
3-18                 (3)  analyze the impact of asthma and allergy on the
3-19     economy of this state and on the health of the residents of this
3-20     state;
3-21                 (4)  make recommendations to the legislature and
3-22     governor  concerning research programs in asthma and allergy and
3-23     funding alternatives for the programs; and
3-24                 (5)  advise the Health and Human Services Commission in
3-25     conducting the children's asthma disease management pilot program
3-26     under Chapter 95, Health and Safety Code, as added by this Act.
3-27           (f)  The asthma and allergy research advisory committee shall
 4-1     meet at least four times as determined by the presiding officer.  A
 4-2     professional facilitator with experience in strategic planning
 4-3     shall facilitate meetings of the committee.
 4-4           (g)  A member of the asthma and allergy research advisory
 4-5     committee may not receive compensation for service on the committee
 4-6     but is entitled to reimbursement for reasonable and necessary
 4-7     travel expenses incurred by the member while conducting the
 4-8     business of the committee as provided by general law and the
 4-9     General Appropriations Act.
4-10           (h)  Not later than December 1, 2002, the commissioner of
4-11     public health shall submit a report prepared by the committee to
4-12     the governor, lieutenant governor, and speaker of the house of
4-13     representatives regarding asthma and allergy that comprehensively
4-14     addresses the issues listed in Subsection (e) of this section.
4-15           SECTION 3.  (a)  The governor shall appoint members to the
4-16     asthma and allergy research advisory committee not later than the
4-17     90th day after the effective date of this Act.
4-18           (b)  The asthma and allergy research advisory committee is
4-19     abolished January 1, 2003.
4-20           (c)  This section and Section 2 of this Act requiring the
4-21     establishment of the asthma and allergy research advisory committee
4-22     expire September 1, 2003.
4-23           SECTION 4.  If before implementing Section 1 of this Act the
4-24     Texas Department of Health determines that a waiver or
4-25     authorization from a federal agency is necessary for
4-26     implementation, the appropriate department shall request the waiver
4-27     or authorization and may delay implementing those provisions until
 5-1     the waiver or authorization is granted.
 5-2           SECTION 5. This Act takes effect September 1, 2001.
         _______________________________     _______________________________
             President of the Senate              Speaker of the House
               I certify that H.B. No. 342 was passed by the House on March
         29, 2001, by a non-record vote; and that the House concurred in
         Senate amendments to H.B. No. 342 on May 24, 2001, by a non-record
         vote.
                                             _______________________________
                                                 Chief Clerk of the House
               I certify that H.B. No. 342 was passed by the Senate, with
         amendments, on May 21, 2001, by a viva-voce vote.
                                             _______________________________
                                                 Secretary of the Senate
         APPROVED:  __________________________
                              Date
                    __________________________
                            Governor